Comprehensive Digestive Stool Analysis 2.0™ (CDSA 2.0)

Comprehensive Digestive Stool Analysis 2.0™ (CDSA 2.0)

The Comprehensive Digestive Stool Analysis 2.0™ (CDSA 2.0) is a gastrointestinal stool test which offers a comprehensive look at the overall health of the gastrointestinal (GI) tract. It helps identify inflammatory conditions such as IBD (Inflammatory Bowel Disease), food allergies, NSAID enteropathy, and post-infectious Irritable Bowel Syndrome (IBS). The CDSA 2.0 stool analysis provides information using advanced biomarkers that evaluate digestion, absorption, pancreatic function, and inflammation, in addition to bacterial balance, yeast, and parasite infection.

Digestive Complaints are Among the Most Common Reasons that Individuals Seek Medical Care
Evidence suggests that both local and systemic health issues may begin as imbalances in GI function. This diagnostic gastrointestinal stool analysis provides immediate, actionable clinical information for the estimated 50% of all patients seen by primary care practitioners who have GI complaints including IBS.

What are the consequences of imbalanced gastrointestinal health?

  • IBS can be the result of maldigestion, malabsorption, dysbiosis, and/or inflammation
  • Maldigestion can result in GI symptoms such as gas, bloating, abdominal pain, constipation or diarrhea
  • Chronic maldigestion can lead to bacterial/fungal overgrowth and alterations in gut permeability. Toxins and large molecules that escape the intestinal barrier can enter the general circulation, inflame the liver, burden the body’s detoxification system, and increase the risk for food allergies, joint disease, and imbalances in overall health.
  • Malabsorption can lead to deficiencies of nutrients, proteins, carbohydrates, and fats. This can result in long term health complications such as anemia, malnutrition, impaired metabolism and other diseases, such as osteoporosis.
  • Chronic dysbiosis can lower the levels of beneficial short chain fatty acids and alter bacterial metabolic activity, thereby increasing the risk of carcinogenesis, hormonal imbalance, and GI inflammation.
  • Altered GI immune function and exposure to bacterial pathogens can lead to diarrhea, mucosal inflammation, intestinal permeability, toxin production, and auto-immune disorders.

Test Type: Stool Analysis


  • Bacteriology Culture, aerobic
  • Bacteriology Culture, aerobic x 3
  • Bacteriology Culture, anaerobic
  • Beneficial SCFAs
  • Beta-Glucuronidase
  • Bile Acids
  • Calprotectin
  • Cryptosporidium EIA
  • Deoxycholic Acid
  • Entamoeba histolytica
  • Eosinophil Protein X (EPX)
  • Giardia lamblia EIA
  • LithoCholic Acid
  • Pancreatic Elastase
  • Parasite Identification, Concentrate Prep
  • Parasite Identification, Trichrome Stain
  • Putrefactive SCFAs
  • Yeast Culture
  • n-Butyrate %
  • pH


  •  Bacteriology Culture, aerobic87045  
  •  Bacteriology Culture, aerobic x 387046  
  •  Bacteriology Culture, anaerobic87075  
  •  Beneficial SCFAs82492  
  •  Beta-Glucuronidase84311  
  •  Bile Acids82239  
  •  Calprotectin83993  
  •  Cryptosporidium EIA87328  
  •  Entamoeba histolytica87336  
  •  Eosinophil Protein X (EPX)83520  
  •  Giardia lamblia EIA87329  
  •  Pancreatic Elastase82656  
  •  Parasite Identification, Concentrate Prep87177  
  •  Parasite Identification, Trichrome Stain87209  
  •  Yeast Culture87102  
  •  pH83986  

Specimen Requirements:  5cc stool in each vial - 3 SAF, 1 Cary Blair, 1 Formalin; 40ml stool in white-top cup. May be random stool or purge.

Turn Around Time: 

14 Days

© 1998 - 2016 Genova Diagnostics (GDX)
This website is intended for educational purposes only. It is not meant for use as diagnostic information and is part of Genova Diagnostics' communication with physicians and patients.